awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q35825968-E13F32F5-687F-4D14-ADA2-441294FE7B10
Q35825968-E13F32F5-687F-4D14-ADA2-441294FE7B10
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35825968-E13F32F5-687F-4D14-ADA2-441294FE7B10
Have COX-2 inhibitors influenced the co-prescription of anti-ulcer drugs with NSAIDs?
P2860
Q35825968-E13F32F5-687F-4D14-ADA2-441294FE7B10
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35825968-E13F32F5-687F-4D14-ADA2-441294FE7B10
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
734e17261588488d7673ce529347cd056b7f09c6
f69db5260aacf11db89fc10f4a026c93384f5af5
P2860
Economic evaluation of celecoxib, a new cyclo-oxygenase 2 specific inhibitor, in Switzerland.